share_log

BioNTech | 6-K: Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine

BioNTech | 6-K: Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine

BioNTech | 6-K:辉瑞和BioNTech的Omicron KP.2适应型COVID-19疫苗获得美国FDA批准和授权
美股SEC公告 ·  08/22 16:36
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息